Up to 500 Amgen employees based at the company’s Thousand Oaks facilities will be relocated to a new site in Tampa, Fla. and other sites, or be terminated, over the next 18 months as part of a new restructuring plan.
Johnson & Johnson’s Human Performance Institute has developed a Premier Executive Leadership program to help executives avoid burnout.
AstraZeneca has won approval for its lung cancer pill Tagrisso in China, a key market for the potential blockbuster medicine.
President Donald Trump suffered a stunning political setback in a Congress controlled by his own party when Republican leaders pulled legislation to overhaul the U.S. healthcare system, a major 2016 election campaign promise of the president and his allies.
The Republican-controlled U.S. House of Representatives cleared the way for a contentious debate on legislation to repeal Obamacare and replace it with a more limited federal healthcare insurance program.
Pfizer Inc. today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending that Trumenba (Meningococcal Group B Vaccine) be granted marketing authorization in the European Union for active immunization of individuals 10 years and older to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB).
A panel of the European Medicines Agency said it recommended granting marketing approval to Danish drugmaker Novo Nordisk’s hemophilia B drug.
Habit and red tape are not sufficient excuses for life sciences organizations to keep doing things the way they always have.
A federal judge dismissed two of the six counterclaims that Express Scripts raised in health insurer’s Anthem’s $15 billion lawsuit claiming it charged too much for drugs.
Eli Lilly and Co. said it would invest $850 million in its U.S. operations during 2017, and the drugmaker signaled it would be willing to spend more if the Trump administration were to overhaul tax laws.
The U.S. FDA approved Symproic (naldemedine) 0.2 mg tablets C-II for treating opioid-induced constipation in adult patients with chronic non-cancer pain.
Get The Study Papers Accomplished Swiftly Without the need of Wasting Time The principle intent behind a study papers would be to instruct pupils more about their topic or task than what the manual gives.
The U.S. FDA approved Bavencio (avelumab) Injection 20 mg/mL for ttreating adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma.
Fast-growing healthcare and pharma agency HYC Health has hired Chris DeProfio as VP, account director, and Jim Kopeny and George Starr as associate creative directors.
Discovery of Novel Screening Test That Can Identify Patients at Risk of Life-Threatening Side Effect with Certain Anticonvulsant Medications
A new genetic test has been discovered that allows for fast and accurate identification of individuals who carry HLA-B*15:02 and who are therefore at risk for a rare yet potentially deadly side effect of certain medications used to treat seizures and bipolar disorder.
Three of Europe’s top drugmakers face critical verdicts from U.S. regulators, with Sanofi and Roche likely to win approvals for two new products while GlaxoSmithKline braces for a potential generic rival.
Shares of Ultragenyx Pharmaceuticals were down after the company announced its Phase II drug UX007 to treat seizures failed to meet trial goals.
Israel-based Teva Pharmaceutical Industries corrected a news report saying the company was cutting 2,000 to 6,000 jobs. The company did not specify the actual number, although it did say 6,000 was too high.
Scientists have found a way to power an experimental kind of electronic skin using solar energy in a further step towards the development of prosthetic limbs or robots with a sense of touch.
GlaxoSmithKline and Regeneron Pharmaceuticals are embarking on a joint project with UK Biobank to hunt for new clues linking genes and disease.